Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Qingxia Fan

Showing results (71-80 of 103) with videos related to

Pageof 11
Sort By:
Small (Weinheim an Der Bergstrasse, Germany)|May 21, 2016
Ultrahigh-Power-Factor Carbon Nanotubes and an Ingenious Strategy for Thermoelectric Performance EvaluationWenbin Zhou, Qingxia Fan, Qiang Zhang, et al.
Journal for Immunotherapy of Cancer|October 16, 2020
HX008, an anti-PD1 antibody, plus irinotecan as second-line treatment for advanced gastric or gastroesophageal junction cancer: a multicenter, single-arm phase II trialYan Song, Ning Li, Qun Li, et al.
The Lancet. Oncology|December 25, 2025
Tiragolumab plus atezolizumab and chemotherapy as first-line treatment for patients with unresectable oesophageal squamous cell carcinoma (SKYSCRAPER-08): a randomised, double-blind, placebo-controlled, phase 3 trialChih-Hung Hsu, Zhihao Lu, Shegan Gao, et al.
Innovation (Cambridge (Mass.))|May 5, 2022
Paclitaxel and cisplatin with or without cetuximab in metastatic esophageal squamous cell carcinoma: a randomized, multicenter phase II trialZhihao Lu, Yanqiao Zhang, Qingxia Fan, et al.
Cancer Biology & Medicine|March 16, 2021
The relationship between treatment-induced hypertension and efficacy of anlotinib in recurrent or metastatic esophageal squamous cell carcinomaYan Song, Juxiang Xiao, Wentao Fang, et al.
Cancer Medicine|February 15, 2021
Anlotinib for previously treated advanced or metastatic esophageal squamous cell carcinoma: A double-blind randomized phase 2 trialJing Huang, Juxiang Xiao, Wentao Fang, et al.
Scientific Reports|October 26, 2013
Super-stretchable, transparent carbon nanotube-based capacitive strain sensors for human motion detectionLe Cai, Li Song, Pingshan Luan, et al.
Eclinicalmedicine|August 20, 2025
Trastuzumab deruxtecan in patients from China with previously treated human epidermal growth factor receptor 2-positive locally advanced/metastatic gastric or gastroesophageal junction adenocarcinoma (DESTINY-Gastric06): results from a single-arm, multicenter, phase 2 trialZhi Peng, Ping Chen, Jin Lu, et al.
Nanoscale|July 3, 2015
Biaxially stretchable supercapacitors based on the buckled hybrid fiber electrode arrayNan Zhang, Weiya Zhou, Qiang Zhang, et al.
Journal of Thoracic Disease|September 13, 2024
Neoadjuvant camrelizumab followed by concurrent camrelizumab plus chemotherapy for locally advanced esophageal squamous cell carcinoma: a single-arm, phase II studyYinliang Sheng, Xiangrui Meng, Chunyang Zhang, et al.
Pageof 11

Showing results (71-80 of 103) with videos related to

Sort By:
Pageof 11
Small (Weinheim an Der Bergstrasse, Germany)|May 21, 2016
Ultrahigh-Power-Factor Carbon Nanotubes and an Ingenious Strategy for Thermoelectric Performance EvaluationWenbin Zhou, Qingxia Fan, Qiang Zhang, et al.
Journal for Immunotherapy of Cancer|October 16, 2020
HX008, an anti-PD1 antibody, plus irinotecan as second-line treatment for advanced gastric or gastroesophageal junction cancer: a multicenter, single-arm phase II trialYan Song, Ning Li, Qun Li, et al.
The Lancet. Oncology|December 25, 2025
Tiragolumab plus atezolizumab and chemotherapy as first-line treatment for patients with unresectable oesophageal squamous cell carcinoma (SKYSCRAPER-08): a randomised, double-blind, placebo-controlled, phase 3 trialChih-Hung Hsu, Zhihao Lu, Shegan Gao, et al.
Innovation (Cambridge (Mass.))|May 5, 2022
Paclitaxel and cisplatin with or without cetuximab in metastatic esophageal squamous cell carcinoma: a randomized, multicenter phase II trialZhihao Lu, Yanqiao Zhang, Qingxia Fan, et al.
Cancer Biology & Medicine|March 16, 2021
The relationship between treatment-induced hypertension and efficacy of anlotinib in recurrent or metastatic esophageal squamous cell carcinomaYan Song, Juxiang Xiao, Wentao Fang, et al.
Cancer Medicine|February 15, 2021
Anlotinib for previously treated advanced or metastatic esophageal squamous cell carcinoma: A double-blind randomized phase 2 trialJing Huang, Juxiang Xiao, Wentao Fang, et al.
Scientific Reports|October 26, 2013
Super-stretchable, transparent carbon nanotube-based capacitive strain sensors for human motion detectionLe Cai, Li Song, Pingshan Luan, et al.
Eclinicalmedicine|August 20, 2025
Trastuzumab deruxtecan in patients from China with previously treated human epidermal growth factor receptor 2-positive locally advanced/metastatic gastric or gastroesophageal junction adenocarcinoma (DESTINY-Gastric06): results from a single-arm, multicenter, phase 2 trialZhi Peng, Ping Chen, Jin Lu, et al.
Nanoscale|July 3, 2015
Biaxially stretchable supercapacitors based on the buckled hybrid fiber electrode arrayNan Zhang, Weiya Zhou, Qiang Zhang, et al.
Journal of Thoracic Disease|September 13, 2024
Neoadjuvant camrelizumab followed by concurrent camrelizumab plus chemotherapy for locally advanced esophageal squamous cell carcinoma: a single-arm, phase II studyYinliang Sheng, Xiangrui Meng, Chunyang Zhang, et al.
Pageof 11